Neurocrine Biosciences
NBIX
#1290
Rank
ยฃ10.90 B
Marketcap
ยฃ107.74
Share price
0.34%
Change (1 day)
12.80%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Number of shares outstanding for Neurocrine Biosciences (NBIX)

Number of shares outstanding as of December 2024 : 101,100,000

According to Neurocrine Biosciences 's latest financial reports and stock price the company's current number of shares outstanding is 101,100,000. At the end of 2024 the company had 101,100,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Neurocrine Biosciences from 1996 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.10 B2.74%
202398.4 M2.18%
202296.3 M1.48%
202194.9 M1.5%
202093.5 M1.41%
201992.2 M1.61%
201890.74 M2.34%
201788.66 M2.06%
201686.87 M0.8%
201586.18 M13.19%
201476.13 M13.06%
201367.34 M1.42%
201266.4 M20.2%
201155.24 M0.74%
201054.84 M40.28%
200939.09 M1.69%
200838.44 M1.2%
200737.99 M0.32%
200637.86 M3.16%
200536.7 M0.77%
200436.42 M13.65%
200332.05 M5.02%
200230.52 M18.23%
200125.81 M17.18%
200022.03 M15.17%
199919.13 M5.22%
199818.18 M13.64%
199716 M-20%
199620 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
56,012,000-44.60%๐Ÿ‡บ๐Ÿ‡ธ USA
447,628,000 342.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
19,845,106-80.37%๐Ÿ‡บ๐Ÿ‡ธ USA
901,000,000 791.20%๐Ÿ‡บ๐Ÿ‡ธ USA
1,769,000,000 1,649.75%๐Ÿ‡บ๐Ÿ‡ธ USA
5,667,000,000 5,505.34%๐Ÿ‡บ๐Ÿ‡ธ USA
19,404,000-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA
24,492,000-75.77%๐Ÿ‡บ๐Ÿ‡ธ USA